Akira Nishiyama Selected Research

Akira Nishiyama Research Topics

Disease

93	Hypertension (High Blood Pressure) 04/2024 - 01/2001
30	Fibrosis (Cirrhosis) 01/2023 - 10/2005
25	Proteinuria 02/2022 - 01/2004
23	Neoplasms (Cancer) 04/2024 - 09/2014
23	Albuminuria 01/2023 - 09/2008
21	Insulin Resistance 04/2024 - 10/2007
20	Type 2 Diabetes Mellitus (MODY) 01/2023 - 09/2008
19	Chronic Renal Insufficiency 12/2023 - 01/2009
18	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 10/2004
16	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 05/2010
15	Inflammation (Inflammations) 02/2024 - 01/2008
13	Ischemia 01/2023 - 11/2003
12	Wounds and Injuries (Trauma) 01/2022 - 04/2005
12	Obesity 11/2021 - 02/2012
10	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 10/2005
9	Glucose Intolerance 04/2024 - 10/2007
9	Body Weight (Weight, Body) 01/2022 - 01/2002
8	Stroke (Strokes) 04/2024 - 05/2006
8	Hyperglycemia 11/2022 - 10/2004
8	Hypoxia (Hypoxemia) 06/2021 - 09/2009
8	Reperfusion Injury 01/2021 - 05/2005
8	Hypertrophy 01/2019 - 07/2007
7	Kidney Diseases (Kidney Disease) 01/2023 - 05/2006
7	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 05/2006
7	Anemia 06/2021 - 09/2017
6	Heart Failure 04/2024 - 04/2007
6	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2019
5	Hemorrhage 03/2023 - 01/2018
5	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2003
4	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 01/2020
4	Adenocarcinoma 01/2023 - 03/2015
4	Pain (Aches) 12/2022 - 08/2014
4	Dyslipidemias (Dyslipidemia) 01/2022 - 12/2012
4	Glycosuria 07/2020 - 12/2015
4	Necrosis 01/2019 - 11/2003
4	Sclerosis 03/2010 - 07/2005
3	Myocardial Infarction 04/2024 - 10/2015

Drug/Important Bio-Agent (IBA)

51	Angiotensin IIIBA 01/2023 - 02/2002
46	SaltsIBA 02/2024 - 01/2003
33	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2004
31	AldosteroneIBA 01/2022 - 01/2004
29	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 03/2005
23	AngiotensinogenIBA 01/2021 - 01/2003
21	ReninIBA 01/2020 - 02/2002
20	Prorenin ReceptorIBA 12/2023 - 05/2006
17	Antihypertensive Agents (Antihypertensives)IBA 04/2024 - 09/2007
16	SodiumIBA 01/2023 - 03/2003
16	olmesartanIBA 01/2023 - 07/2004
15	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 05/2016
15	Messenger RNA (mRNA)IBA 11/2021 - 05/2006
14	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 01/2001
14	Angiotensin Receptor AntagonistsIBA 01/2023 - 08/2008
13	Eplerenone (Inspra)FDA LinkGeneric 01/2021 - 04/2004
12	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2022 - 04/2012
10	CreatinineIBA 01/2023 - 08/2011
10	AngiotensinsIBA 01/2022 - 01/2003
10	Insulin (Novolin)FDA Link 01/2022 - 10/2007
10	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021 - 04/2005
10	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2014 - 05/2005
9	CateninsIBA 12/2023 - 03/2015
8	Peptides (Polypeptides)IBA 01/2020 - 10/2004
7	Sodium-Glucose Transport ProteinsIBA 04/2024 - 12/2015
7	CollagenIBA 01/2023 - 01/2005
7	Erythropoietin FDA Link 01/2021 - 02/2016
7	Hydralazine (Apresoline)FDA LinkGeneric 03/2020 - 03/2004
6	AntioxidantsIBA 09/2022 - 03/2006
6	AlbuminsIBA 01/2021 - 09/2008
6	Chymases (Chymase)IBA 11/2018 - 08/2008
6	candesartanIBA 01/2018 - 10/2003
6	Superoxides (Superoxide)IBA 01/2014 - 02/2003
6	tempolIBA 01/2012 - 03/2004
5	Blood Glucose (Blood Sugar)IBA 01/2023 - 09/2008
5	Retinaldehyde (Retinal)IBA 10/2022 - 03/2012
5	esaxerenoneIBA 08/2022 - 01/2019
5	Transcription Factors (Transcription Factor)IBA 06/2022 - 11/2013
5	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 11/2013
5	Drinking WaterIBA 01/2022 - 07/2004
5	Immunoglobulin A (IgA)IBA 01/2022 - 05/2006
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2014
5	aliskiren FDA Link 10/2018 - 05/2010
4	Mineralocorticoid Receptor AntagonistsIBA 01/2023 - 03/2010
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023 - 09/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 09/2009
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2018
4	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 06/2021 - 02/2016
4	Adenine FDA LinkGeneric 12/2020 - 09/2017
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020 - 06/2009
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 06/2007
4	Valsartan (Vals)FDA Link 03/2020 - 08/2008
4	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2018 - 09/2011
4	Renin InhibitorsIBA 10/2018 - 05/2010
4	Type 1 Angiotensin ReceptorIBA 01/2017 - 10/2003
4	Epoxide HydrolasesIBA 07/2015 - 02/2013
4	FructoseIBA 11/2013 - 09/2009
4	Angiotensin II Type 1 Receptor BlockersIBA 01/2013 - 09/2008

Therapy/Procedure

24	Therapeutics 02/2024 - 07/2005
6	Denervation 02/2024 - 11/2003
5	Surgical Instruments (Clip) 04/2022 - 03/2011
5	Nephrectomy 06/2021 - 11/2003
4	Oral Administration 06/2018 - 12/2010